These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7852975)

  • 1. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation.
    Dummer S; Lee A; Breinig MK; Kormos R; Ho M; Griffith B
    J Med Virol; 1994 Nov; 44(3):305-9. PubMed ID: 7852975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis.
    Adler SP; Hur JK; Wang JB; Vetrovec GW
    J Infect Dis; 1998 Jan; 177(1):209-12. PubMed ID: 9419190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.
    Grattan MT; Moreno-Cabral CE; Starnes VA; Oyer PE; Stinson EB; Shumway NE
    JAMA; 1989 Jun 23-30; 261(24):3561-6. PubMed ID: 2542633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
    Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
    BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.
    Zhou YF; Leon MB; Waclawiw MA; Popma JJ; Yu ZX; Finkel T; Epstein SE
    N Engl J Med; 1996 Aug; 335(9):624-30. PubMed ID: 8687516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
    Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
    Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study.
    Sorlie PD; Nieto FJ; Adam E; Folsom AR; Shahar E; Massing M
    Arch Intern Med; 2000 Jul; 160(13):2027-32. PubMed ID: 10888976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients.
    Fang JC; Kinlay S; Kundsin R; Ganz P
    Am J Cardiol; 1998 Dec; 82(12):1479-83. PubMed ID: 9874051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease.
    Betjes MG; Litjens NH; Zietse R
    Nephrol Dial Transplant; 2007 Nov; 22(11):3298-303. PubMed ID: 17597084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
    Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Schafhausen P; Jaburg N; Löliger C; Schäfer P; Hinke A; Zander AR
    Br J Haematol; 2001 Jun; 113(4):1060-71. PubMed ID: 11442503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study.
    Sambiase NV; Higuchi ML; Nuovo G; Gutierrez PS; Fiorelli AI; Uip DE; Ramires JA
    Mod Pathol; 2000 Feb; 13(2):173-9. PubMed ID: 10697275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients.
    Potena L; Grigioni F; Magnani G; Lazzarotto T; Musuraca AC; Ortolani P; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2009 May; 28(5):461-7. PubMed ID: 19416774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytomegalovirus infection and coronary sclerosis after heart transplantation].
    Loebe M; Schüler S; Spiegelsberger S; Warnecke H; Fleck E; Hetzer R
    Dtsch Med Wochenschr; 1990 Aug; 115(34):1266-9. PubMed ID: 2167829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty.
    Manegold C; Alwazzeh M; Jablonowski H; Adams O; Medve M; Seidlitz B; Heidland U; Häussinger D; Strauer BE; Heintzen MP
    Circulation; 1999 Mar; 99(10):1290-4. PubMed ID: 10077511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.
    Zhu J; Quyyumi AA; Norman JE; Csako G; Epstein SE
    J Am Coll Cardiol; 1999 Nov; 34(6):1738-43. PubMed ID: 10577564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
    Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J
    Ann Hematol; 2019 Jul; 98(7):1755-1763. PubMed ID: 30993417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection?
    Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Kopp H; Rippin G; Hafner G; Pfeifer U; Meyer J
    Stroke; 2000 Sep; 31(9):2127-33. PubMed ID: 10978041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.